Introduction
Type 2 Diabetes Mellitus [DM] incidence is increasing worldwide, and it can be due to many risk factors such as genetic, environmental or behavioral factors. [1] It is suggested through epidemiological data that 90% of type 2 diabetes cases are due to lifestyle and modifiable habits. [2] The main non-genetic risk factor is obesity. So, weight loss was shown to delay type 2 DM, however solely it is hard to maintain and depend on. [3] [4] [5] The patients were classified into two groups; 120 (52.4%) controlled and 109 (47.6%) uncontrolled, according to level of HbA1c and/or FBG, so patients with HbA1c of 7% or less are in the controlled group and if above 7% are in the uncontrolled group and FBG of 7 mmol/L or less are in the controlled group and above 7 mmol/L are in the uncontrolled group.
Out of the total 229 patients; 120 were controlled patients 63 (52.5%) were males and 57 (47.5%) were females. As for the remaining 109 uncontrolled DM patients; 63 (57.8%) of them were males, and 46 (42.2%) were females. The mean age for both groups was 49.2±12.7 and 50.1±12.6 years, for controlled and uncontrolled patients respectively.
Diabetic patients often suffer from vitamin D deficiency (142 patients), dyslipidemia (104 patients) and hypertension (75 patients). The highest was vitamin D deficiency, 79 (65.8%) and 63 (57.8%) for controlled and uncontrolled patients, respectively, as seen in table 1.
As for type 2 DM treatments; different treatments were used oral hypoglycemic, insulin only, insulin & oral hypoglycemic and diet only, as seen in table 2.
Results
The hba1c and FBG were measured at the start and at the end of the study for all patients. Hba1c decreased 15.4% in controlled DM patients, while it decreased by 6.0% in uncontrolled DM patients. Showing highly statistical significant results (p-value 0.007) between the two groups. As for FBG, it decreased by 24.9% and 8.1% for controlled and uncontrolled respectively, with no significant statistical difference in either groups, as seen in table 3.
For the overall sample, there was a decrease in both hba1c and FBG by 10.7% and 15.9% respectively for patients taking oral hypoglycemic, both hba1c and FBG showed a very highly The controlled DM group, total cholesterol, LDL-C, HDL-C, and triglycerides showed percent changes by -11.2%, -11.1%, 19.8%, -30.4%, respectively. And for the uncontrolled DM group, showed significant percent changes by -4.8%, -0.8%, 3.1% & -3.4% respectively between first and last visits, as seen in table 5.
Vitamin D results at base line and at the end of the study for both controlled and uncontrolled was very highly statistically
Discussion
According to the UK Prospective Diabetes Study [UKPDS], controlled DM type 2 patients achieving median of 7.0% hba1c, have shown a significant reduction in micro-vascular risk of complications and a decrease in myocardial infarction incidence, compared with 7.9% median of hba1c, over a median of 10 years of follow up.
[18] Patients with type 2 diabetes have an increased prevalence of lipid abnormalities, contributing to their high risk of CVD. [22, 23] In our study; we have measured various parameters to see the contrast between controlled and uncontrolled type 2 diabetic patients. The aim of diabetes control is to maintain normal blood glucose levels and to achieve hba1c of 7.0%. Hba1c and FBG decreased by the end of the study. Hba1c decreased by 15 Another study performed in Kumamoto, Japan compared 100 randomized type 2 diabetic patients with intensive and conventional insulin therapy, and were followed up for 6 years. The intensively treated group had less retinopathy [13% vs 38%, p=0.007], nephropathy [10% vs 30%, p=0.005], and neuropathy [12.8% vs 64.6% increase in lower extremity vibration threshold, p< 0.05] than the conventionally treated group. The hba1c levels at the end of the study were 7.1% vs 9.4% in the two groups, respectively. [25] It was also seen that the treatment with metformin showed a significant advantage over the conventional treatment in obese patients [n=1704]: a 32% reduction of diabetes-related end points [p=0.002], a 42% reduction of diabetes-related deaths [p=0.017], and a 36% reduction of all-cause mortality [p=0.011]. Patients taking metformin also had less weight gain and fewer hypoglycemic attacks than those taking insulin or sulfonylureas. The above results show that the complications in type 2 diabetes are reduced through the reduction of blood glucose. [24] In our study, for patients taking oral hypoglycemic there was a decrease in both hba1c and FBG by 10.7% and 15.9% respectively [p-value 0.000]. Also in patients taking both insulin & oral hypoglycemic; there was a decrease in hba1c & FBG between the start and end of the study, by -10.7% [p value 0.000] and -20.2% [p-value 0.020] respectively. As for patients taking insulin only, by -7.4% and -12.7% for hba1c and FBG respectively, and patients only regulating diet; there was a decrease in hba1c and an increase in FBG, by -6.3% and 3.1% respectively. This conveys how controlling diabetes shows significant difference in regulating both hba1c and FBG.
Another similar trial randomized 153 men with type 2 diabetes to intensive control or standard therapy. At the end of 27 months of follow-up, the mean hba1c values were significantly lower in the intensive group [7.3% vs 9.4%; p <0.001]. [26] In a previous study, it was illustrated that the median for hba1c was 8.4% for conventional therapy and 6.9% for intensive therapy. [27] Also, it was seen that the risk for micro-vascular problems decreases by 37% and the risk of mortality decreases by 21% for each 1% reduction in hba1c. [28] [29] [30] The incidence of micro-vascular risk was lower than that of myocardial infarction in patients with the lowest category of mean hba1c. [11] This illustrates how hyperglycemia may be a contributing factor for cardiovascular risk for diabetic patients, rather than only the conventional risks, such as smoking, hypertension and dyslipidemia. [31] Numerous studies, which were conducted to observe the correlation between Vitamin D insufficiency and type 2 DM, is recently being investigated to see the links and correlation between them. [32] [33] Vitamin D insufficiency is common in type 2 DM patients, resulting in lowering insulin secretion from the pancreas, however with no alterations in glucagon secretion. [34] Evidence show that supplementation of vitamin D in type 2 DM patients improves impaired glucose tolerance and insulin resistance through increasing the release of pancreatic insulin by and controlled groups, it was shown to increase Vitamin D level by; 121.4% and 124.3% respectively, both showing very highly significant results in our study [p-value 0.000], that vitamin D status has an effect on diabetes mellitus type 2 control. Vitamin D enhances calcium reabsorption by the kidney and increases the ingested calcium uptake by the gut, leading to the increase of both minerals in the plasma. [39] So, previous studies were made to see the effect of Vitamin D on insulin and its resistance, however in our study we investigate the effect of diabetes control on vitamin D levels and by subsequence the effect on Calcium levels.
Numerous studies have also been made on the correlation between calcium status and diabetes. It has been found that calcium levels are lower in diabetic patients compared to control non-diabetic patients. [40] It was also seen in some prospective studies that low calcium intake is inversely correlated with type 2 DM incidence. [41] [42] [43] [44] However, in our study serum calcium showed non-significant results when related to diabetes in either groups p=0.109 and p=0.832 for the uncontrolled group and controlled group, respectively. Dyslipidemia is one of the main diseases that accompany Diabetes Mellitus, so lipid concentration is a marker of the condition. A prior study illustrated that improved glycemic control has been shown to lower LDL_C levels, [45] [46] [47] [48] which theoretically should lower the risk of developing CHD for patients with diabetes. [49] [50] [51] [52] In this study, it was seen that controlled patients showed a better lipid profile than uncontrolled patients, since total cholesterol, LDL-C and Triglyceride [TG] levels declined more in controlled patients and HDL-C increased more in controlled patients. The cholesterol level decreased from base line to the end of the study by 4.8% and 11.2%, for uncontrolled [p-value 0.134] and controlled [p-value 0.002] patients stimulating its synthesis in pancreatic islets. [34] [35] There are data that also link and suggest that low vitamin D level might be causally linked to impaired insulin sensitivity. [36] [37] [38] It was also found that endothelial function, which is a powerful marker for cardiovascular risk is improved with vitamin D supplementation. [34] In our study vitamin D was investigated in both uncontrolled
